comparemela.com
Home
Live Updates
EYLEA® Proposed Biosimilar M710 BPCIA Appeals Dismissed
EYLEA® Proposed Biosimilar M710 BPCIA Appeals Dismissed
EYLEA® Proposed Biosimilar M710 BPCIA Appeals Dismissed for Lack of Jurisdiction | Venable LLP
On April 12, 2024, the Federal Circuit dismissed CAFC Appeal No. 24-1402 and Cross-Appeal No. 24-1405 for lack of jurisdiction following its February 22, 2024 order directing Regeneron...
Related Keywords
April Breyer Menon ,
Formycon Klinge Biopharma ,
Mylan Biocon ,
District Court ,
Biocon ,
Federal Circuit ,
Klinge Biopharma ,
Samsung Bioepis ,